These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Ribonucleases as a novel pro-apoptotic anticancer strategy: review of the preclinical and clinical data for ranpirnase. Costanzi J; Sidransky D; Navon A; Goldsweig H Cancer Invest; 2005; 23(7):643-50. PubMed ID: 16305992 [TBL] [Abstract][Full Text] [Related]
11. Ribonucleases as novel chemotherapeutics : the ranpirnase example. Lee JE; Raines RT BioDrugs; 2008; 22(1):53-8. PubMed ID: 18215091 [TBL] [Abstract][Full Text] [Related]
13. Ranpirnase (Onconase), a cytotoxic amphibian ribonuclease, manipulates tumour physiological parameters as a selective killer and a potential enhancer for chemotherapy and radiation in cancer therapy. Lee I Expert Opin Biol Ther; 2008 Jun; 8(6):813-27. PubMed ID: 18476793 [TBL] [Abstract][Full Text] [Related]
14. Ranpirnase as a potential antitumor ribonuclease treatment for mesothelioma and other malignancies. Beck AK; Pass HI; Carbone M; Yang H Future Oncol; 2008 Jun; 4(3):341-9. PubMed ID: 18518759 [TBL] [Abstract][Full Text] [Related]